Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy

• Status: Completed
• Trial end date: 2014-09-23
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the safety and efficacy of cyclosporine 0.05% ophthalmic emulsion (Restasis®) in patients with dry eye disease.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Carboxymethylcellulose Sodium; Cyclosporine; Cyclosporins; Lubricant Eye Drops; Ophthalmic Solutions; Tetrahydrozoline

Criteria

Inclusion Criteria:

• History of dry eye in both eyes

• Willing to use eye drops for dry eye symptoms

Exclusion Criteria:

• Anticipate wearing contact lenses during the study

• Laser-assisted in situ keratomileusis (LASIK) surgery within the past 12 months

• Any ocular and/or lid surgeries within the past 6 months

• Cataract surgery in either eye

• Current or anticipated use of temporary punctal plugs during the study